UK presses on with trial transparency despite legal challenge
This article was originally published in SRA
Executive Summary
It's not clear why Richmond Pharmacology has decided to challenge the UK Health Research Authority's clinical trial transparency policies, but it could well be that the London-based CRO has the authority's new requirement on trial registration in its sights1. Transparency campaigners have criticised the move.